APDN to Report FQ1’2024 Financial Results on Thursday, February 8, 2024
February 5th, 2024
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Press Release
APDN Announces $3.44M Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 31st, 2024
APDN Announces JDA to Integrate Linea™ IVT Platform into Kudo Biotechnology’s mRNA Manufacturing Workflow
December 14th, 2023
APDN Announces Fourth Quarter Fiscal Year 2023 Financial Results
December 7th, 2023
APDN to Report FQ4’23 and Year End Financial Results 12/7/23
December 5th, 2023
APDN Announces Linea™ DNA Follow-On Order for Cancer Diagnostic Application
November 28th, 2023
APDN Extends Application of Linea™ IVT Platform to saRNA (self-amplifying mRNA)
November 16th, 2023
APDN Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea™ DNA Platform
November 9th, 2023
APDN Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
September 14th, 2023